{
    "Trade/Device Name(s)": [
        "NoCoding1 Plus Blood Glucose Monitoring System",
        "VeraSens Blood Glucose Monitoring System"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K171480",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160742"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "November 10, 2017",
    "Summary Letter Received Date": "November 13, 2017",
    "Submission Date": "December 13, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "NoCoding1 Plus Blood Glucose Meter",
        "VeraSens Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for NoCoding1 Plus and VeraSens blood glucose monitoring systems with Bluetooth data transfer for home diabetes management",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertips for self-testing at home by individuals with diabetes; not intended for neonates or for diagnosis/screening of diabetes; single person use.",
    "fda_folder": "Clinical Chemistry"
}